RAC 1.78% $1.66 race oncology ltd

General Comments / Chat, page-4113

  1. 2,941 Posts.
    lightbulb Created with Sketch. 3564
    It's the same back and forth process with any regulatory body.

    I still feel IP security is our largest commercial risk but it was significantly reduced when the COH patent application was rejected and Prof Chen joined our SAB.

    COH either have no claim or we've struck an in principle agreement with them not to proceed. Both scenarios are positive.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.